Skip to main content

Table 4 Clinical characteristics of early recurrence

From: Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation

Characteristics

Low risk group

High risk group

Short interval

Long interval

P

Short interval

Long interval

P

Patients

65

25

 

79

21

 

Relapse location (%)

  

0.868

  

0.383

 Local

26 (40.6)

11 (44.0)

 

29 (37.2)

5 (23.8)

 

 Intrahepatic distant

37 (57.8)

14 (56.0)

 

47 (60.3)

15 (71.4)

 

 Extrahepatic

1.0 (1.6)

0.0 (0.0)

 

2 (2.6)

1 (4.8)

 

Intrahepatic tumor number

1.0 (1.0)

1.5 (1.0)

0.811

1.0 (1.0)

2.0 (1.0)

0.229

Intrahepatic tumor size (cm)

1.7 (1.5)

1.9 (1.9)

0.718

1.9 (1.5)

1.6 (1.3)

0.797

Curative intent (%)

44.0 (77.2)

18.0 (81.8)

0.886

43 (64.2)

6 (37.5)

0.087

BCLC (%)

  

0.172

  

0.028

 0

19 (29.2)

6 (24.0)

 

15 (19.0)

2 (9.5)

 

 A

35 (53.8)

12 (48.0)

 

46 (58.2)

10 (47.6)

 

 B

7 (10.8)

5 (20.0)

 

8 (10.1)

3 (14.3)

 

 C & D

4 (6.2)

2 (8.0)

 

10 (12.7)

6 (28.6)

 
  1. Abbreviations: BCLC Barcelona clinic liver cancer stage
  2. Values are presented as the median (IQR), or n (%)
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us